Shandong Sino-Agri United Biotechnology Co Ltd (003042) - Total Assets
Based on the latest financial reports, Shandong Sino-Agri United Biotechnology Co Ltd (003042) holds total assets worth CN¥3.93 Billion CNY (≈ $575.63 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can Shandong Sino-Agri United Biotechnology service its debt to assess how comfortably operating cash covers total debt obligations.
Shandong Sino-Agri United Biotechnology Co Ltd - Total Assets Trend (2015–2025)
This chart illustrates how Shandong Sino-Agri United Biotechnology Co Ltd's total assets have evolved over time, based on quarterly financial data. See what is Shandong Sino-Agri United Biotechnology 's book value for net asset value and shareholders' equity analysis.
Shandong Sino-Agri United Biotechnology Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Shandong Sino-Agri United Biotechnology Co Ltd's total assets of CN¥3.93 Billion consist of 33.8% current assets and 66.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 4.4% |
| Accounts Receivable | CN¥328.05 Million | 8.6% |
| Inventory | CN¥550.74 Million | 14.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥173.06 Million | 4.5% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2015–2025)
This chart illustrates how Shandong Sino-Agri United Biotechnology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Shandong Sino-Agri United Biotechnology (003042) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shandong Sino-Agri United Biotechnology Co Ltd's current assets represent 33.8% of total assets in 2025, a decrease from 35.0% in 2015.
- Cash Position: Cash and equivalents constituted 4.4% of total assets in 2025, down from 7.5% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 3.0% in 2015.
- Asset Diversification: The largest asset category is inventory at 14.4% of total assets.
Shandong Sino-Agri United Biotechnology Co Ltd Competitors by Total Assets
Key competitors of Shandong Sino-Agri United Biotechnology Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Yangnong Chemical Co Ltd
SHG:600486
|
China | CN¥19.12 Billion |
|
Lier Chemical Co Ltd
SHE:002258
|
China | CN¥16.78 Billion |
|
Cangzhou Dahua Co Ltd
SHG:600230
|
China | CN¥6.04 Billion |
|
Liuzhou Chemical Industry Co Ltd
SHG:600423
|
China | CN¥618.15 Million |
|
Jiangsu Fengshan Group Co Ltd
SHG:603810
|
China | CN¥2.74 Billion |
|
Namhae Chemical
KO:025860
|
Korea | ₩841.45 Billion |
|
Boa Safra Sementes S.A
SA:SOJA3
|
Brazil | R$3.46 Billion |
|
Kyung Nong Corporation
KO:002100
|
Korea | ₩486.46 Billion |
Shandong Sino-Agri United Biotechnology Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.58 | 0.70 | 1.41 |
| Quick Ratio | 0.36 | 0.46 | 1.17 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-1.07 Billion | CN¥-584.13 Million | CN¥441.54 Million |
Shandong Sino-Agri United Biotechnology Co Ltd - Advanced Valuation Insights
This section examines the relationship between Shandong Sino-Agri United Biotechnology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.02 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | -2.8% |
| Total Assets | CN¥3.82 Billion |
| Market Capitalization | $259.78 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shandong Sino-Agri United Biotechnology Co Ltd's assets below their book value (0.07x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Shandong Sino-Agri United Biotechnology Co Ltd's assets decreased by 2.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Shandong Sino-Agri United Biotechnology Co Ltd (2015–2025)
The table below shows the annual total assets of Shandong Sino-Agri United Biotechnology Co Ltd from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥3.82 Billion ≈ $559.41 Million |
-2.82% |
| 2024-12-31 | CN¥3.93 Billion ≈ $575.66 Million |
+5.09% |
| 2023-12-31 | CN¥3.74 Billion ≈ $547.79 Million |
+5.84% |
| 2022-12-31 | CN¥3.54 Billion ≈ $517.54 Million |
+9.82% |
| 2021-12-31 | CN¥3.22 Billion ≈ $471.26 Million |
+39.99% |
| 2020-12-31 | CN¥2.30 Billion ≈ $336.63 Million |
+21.94% |
| 2019-12-31 | CN¥1.89 Billion ≈ $276.06 Million |
+5.41% |
| 2018-12-31 | CN¥1.79 Billion ≈ $261.89 Million |
+10.85% |
| 2017-12-31 | CN¥1.61 Billion ≈ $236.25 Million |
+14.76% |
| 2016-12-31 | CN¥1.41 Billion ≈ $205.87 Million |
+23.21% |
| 2015-12-31 | CN¥1.14 Billion ≈ $167.09 Million |
-- |
About Shandong Sino-Agri United Biotechnology Co Ltd
Shandong Sino-Agri United Biotechnology Co.,Ltd engages in the development and production of pesticide intermediates and preparation products in China. The company's products include imidacloprid, acetamiprid, (E)-nitenpyram, pyridaben, intermediates, pesticides, fungicides, and herbicides. It also exports its products to Southeast Asia, South Asia, the Middle East, Europe, and the United States.… Read more